Sunshine Biopharma Inc.

02/02/2021 | Press release | Archived content

SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT APPLICATION EXTENDING PROTECTION OF ADVA-27A IN CANADA UNTIL 2033